INIS
cancer
100%
breasts
96%
patients
80%
hospitals
44%
surgery
44%
metastases
42%
thyroid
37%
tumors
32%
chemotherapy
26%
carcinomas
25%
indonesia
22%
thyroidectomy
19%
lymph nodes
18%
bones
18%
therapy
18%
evaluation
16%
sarcomas
16%
fluorouracils
16%
diseases
13%
data
11%
tissues
10%
hazards
10%
women
9%
hyperparathyroidism
9%
drugs
8%
risks
8%
covid-19
8%
radiations
8%
doxorubicin
8%
plasminogen
8%
plasma
8%
kinases
8%
adriamycin
8%
transformations
8%
migration
8%
reductases
8%
proteins
8%
compartments
8%
limbs
8%
kidneys
8%
failures
8%
injuries
8%
humans
8%
cyclophosphamide
8%
glycoproteins
8%
liver
8%
correlations
7%
volume
6%
size
6%
control
5%
Keyphrases
Locally Advanced Breast Cancer
38%
Indonesia
33%
Breast Cancer Patients
32%
Breast Cancer
27%
Simvastatin
24%
Papillary Thyroid Carcinoma
24%
Neoadjuvant Chemotherapy
18%
Adriamycin
16%
Fluorouracil
16%
5-year Survival
16%
Cyclophosphamide
16%
Bone Metastasis
16%
Endoscopic Thyroidectomy
16%
Lymphovascular Invasion
15%
General Hospital
15%
Predictive Factors
12%
Thyroid Nodule
11%
Tumor
10%
Confidence Interval
10%
Metastasis
10%
Response to Neoadjuvant Chemotherapy
9%
Mastectomy
9%
Squamous Cell Carcinoma (SqCC)
9%
Human Epidermal Growth Factor Receptor 2 (HER2)
9%
Survival Analysis
9%
Hazard Ratio
9%
Indonesian
9%
Tumor Size
8%
Latissimus Dorsi Flap
8%
Cancer Epidemiology
8%
Extremity Soft Tissue Sarcoma
8%
Flap Reconstruction
8%
Indeterminate Thyroid Nodules
8%
Rho Associated Coiled-coil Containing Protein Kinase 1
8%
Single-center Study
8%
Cancer of Unknown Primary
8%
Cancer Cell Migration
8%
BRAF mutation
8%
Diagnostic Value
8%
Surgical Perspective
8%
P-glycoprotein Expression
8%
Doxorubicin
8%
Cancer Registry Data
8%
Parathyroid Carcinoma
8%
Tertiary Hospital
8%
Comprehensive Evaluation
8%
Referral Hospital
8%
COVID-19 Pandemic
8%
Hydroxymethylglutaryl-CoA Reductases
8%
Anthracyclines
8%
Medicine and Dentistry
Breast Cancer
34%
Neoplasm
27%
Papillary Thyroid Cancer
24%
Thyroidectomy
18%
Bone Metastasis
16%
Neoadjuvant Chemotherapy
16%
Locally Advanced Breast Cancer
16%
Malignant Neoplasm
15%
Lymphovascular Invasion
12%
Thyroid Nodule
11%
Neck
11%
Metastatic Carcinoma
10%
Lymph Node Metastasis
10%
Cancer
9%
Cancer Registry
9%
Survival Analysis
9%
Hazard Ratio
9%
Squamous Cell Carcinoma
9%
Diagnosis
9%
Survival Rate
9%
Overall Survival
8%
Latissimus Dorsi Flap
8%
Soft Tissue Sarcoma
8%
Doxorubicin
8%
COVID-19
8%
Cross Sectional Study
8%
Secondary Hyperparathyroidism
8%
Parathyroid Carcinoma
8%
Patient Referral
8%
Transcatheter Arterial Chemoembolization
8%
Chronic Kidney Disease
8%
Cancer of Unknown Primary Origin
8%
Limb
8%
Forequarter Amputation
8%
Cancer Epidemiology
8%
Synovial Sarcoma
8%
Triple Negative Breast Cancer
8%
ABC Transporter Subfamily B
8%
Prognostic Factor
8%
Plasminogen Activator Inhibitor-1
8%
Anthracycline
8%
Bleeding
6%
Parathyroid Hormone
6%
Thyroid Gland
5%
Recurrent Disease
5%
